| P50 | author | Hans-Christian Bauer | Q50638848 |
| P2093 | author name string | Bernhard Hennig | |
| | Herbert Tempfer | |
| | Christine Lehner | |
| | Renate Gehwolf | |
| | Hannelore Bauer | |
| | Hans-Christian Bauer | |
| | Istvan Krizbai | |
| P2860 | cites work | Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage | Q85122458 |
| | Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 |
| | Transcriptional activation of human matrix metalloproteinase-9 gene expression by multiple co-activators | Q24289430 |
| | Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals | Q24310136 |
| | Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins | Q24324232 |
| | The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration | Q24644214 |
| | Neuroprotection for ischemic stroke: past, present and future | Q24645185 |
| | A new view of carcinogenesis and an alternative approach to cancer therapy | Q24650249 |
| | Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol | Q24652967 |
| | Redox mechanisms in hepatic chronic wound healing and fibrogenesis | Q24656684 |
| | Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells | Q24679401 |
| | Molecular basis of phosphorylation-induced activation of the NADPH oxidase | Q27641143 |
| | Free radicals in the physiological control of cell function | Q27860480 |
| | The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity | Q28138221 |
| | Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury-induced brain trauma | Q28141561 |
| | The JAM family of junctional adhesion molecules | Q28205895 |
| | Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells | Q28208656 |
| | Multifunctional strands in tight junctions | Q28210051 |
| | The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B | Q28211466 |
| | p53 regulates mitochondrial respiration | Q28242400 |
| | Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells | Q28251122 |
| | Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site | Q28286400 |
| | Why do cancers have high aerobic glycolysis? | Q28290710 |
| | Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes | Q28367951 |
| | Peroxynitrite: biochemistry, pathophysiology and development of therapeutics | Q29615424 |
| | Structure and function of the blood-brain barrier | Q29615699 |
| | The blood-brain barrier/neurovascular unit in health and disease | Q29616335 |
| | Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 |
| | Reactive oxygen species have a causal role in multiple forms of insulin resistance | Q29619831 |
| | How matrix metalloproteinases regulate cell behavior | Q29620360 |
| | ZO proteins and redox-dependent processes. | Q30155864 |
| | Junctional music that the nucleus hears: cell-cell contact signaling and the modulation of gene activity. | Q30384261 |
| | Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein | Q30434808 |
| | Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex | Q72139366 |
| | Circulating xanthine oxidase in human ischemia reperfusion | Q72155648 |
| | c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability | Q74243929 |
| | Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro | Q74299346 |
| | RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs) | Q77698598 |
| | A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor | Q78423901 |
| | Protein oxidation and aging | Q79336883 |
| | Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia | Q37176938 |
| | Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase | Q37177525 |
| | Redox regulation of cell survival | Q37181226 |
| | Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? | Q37281878 |
| | Tight junctions at a glance | Q37318516 |
| | Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability | Q37344103 |
| | Tight junctions and the regulation of gene expression | Q37361719 |
| | NOX2 inhibition with apocynin worsens stroke outcome in aged rats | Q37362268 |
| | Cerebral blood flow regulation by nitric oxide: recent advances | Q37416850 |
| | Redox control of the cell cycle in health and disease | Q37510851 |
| | CNS pericytes: concepts, misconceptions, and a way out. | Q37522167 |
| | The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. | Q37603088 |
| | The role of NF-kappaB in hypoxia-induced gene expression. | Q37618866 |
| | Inflammatory mechanisms in ischemic stroke: therapeutic approaches | Q37634142 |
| | Oxidative stress and oxidative damage in carcinogenesis | Q37658133 |
| | Dynamics and functions of tight junctions | Q37671362 |
| | The dual role of zonula occludens (ZO) proteins | Q37708020 |
| | New aspects of the molecular constituents of tissue barriers | Q37791921 |
| | The Nrf2 system as a potential target for the development of indirect antioxidants. | Q37802176 |
| | Occludin protein family: oxidative stress and reducing conditions | Q37828522 |
| | Pathobiology of junctional adhesion molecules | Q37831307 |
| | Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species | Q37835837 |
| | Protein phosphorylation associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium | Q37878450 |
| | Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury | Q38298161 |
| | Expression and regulation of toll-like receptors in cerebral endothelial cells. | Q39679370 |
| | Cellular mechanisms of IL-17-induced blood-brain barrier disruption | Q39770425 |
| | Matrix metalloproteinases in cerebral ischemia | Q40028510 |
| | Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling | Q40116310 |
| | Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability | Q40131334 |
| | Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells | Q40215633 |
| | Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. | Q40322378 |
| | Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. | Q40442621 |
| | Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. | Q40464070 |
| | Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts | Q40512855 |
| | The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury | Q40554667 |
| | Peroxynitrite mediates nitric oxide-induced blood-brain barrier damage. | Q40574996 |
| | The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. | Q40599754 |
| | 4-Hydroxynonenal impairs the permeability of an in vitro rat blood-brain barrier | Q40769377 |
| | Induced expression of adhesion molecules following focal brain ischemia | Q40965337 |
| | Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface | Q42161344 |
| | Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch | Q42173741 |
| | Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells | Q42474889 |
| | Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia | Q42475527 |
| | Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure | Q42529285 |
| | S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death | Q30843579 |
| | Expression of nitric oxide synthases and nitrotyrosine during blood-brain barrier breakdown and repair after cold injury | Q32005857 |
| | Diabetic beta-cells can achieve self-protection against oxidative stress through an adaptive up-regulation of their antioxidant defenses. | Q33490595 |
| | Endothelial cell specific adhesion molecule (ESAM) localizes to platelet-platelet contacts and regulates thrombus formation in vivo | Q33501329 |
| | The many functions of APE1/Ref-1: not only a DNA repair enzyme | Q33609187 |
| | Mmp-9, a potential target for cerebral ischemic treatment | Q33612510 |
| | The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells | Q33741896 |
| | Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils | Q33761398 |
| | Leukocyte recruitment and ischemic brain injury | Q33886526 |
| | TRPC-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress | Q33929797 |
| | Reactive oxygen radicals in signaling and damage in the ischemic brain | Q33930675 |
| | Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier | Q33951351 |
| | Methionine oxidation and aging | Q33984659 |
| | Oxidative stress and cancer: have we moved forward? | Q34001313 |
| | Nuclear localization of the tight junction protein ZO-2 in epithelial cells | Q34115117 |
| | Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement | Q34170971 |
| | Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. | Q34171371 |
| | VEGF in brain tumors | Q34178821 |
| | Progesterone and allopregnanolone attenuate blood–brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases | Q34235491 |
| | The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses | Q34387881 |
| | Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium | Q34480588 |
| | Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. | Q34507928 |
| | Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation | Q34571497 |
| | Structure and function of claudins. | Q34585322 |
| | The cytoplasmic plaque of tight junctions: a scaffolding and signalling center | Q34761497 |
| | Matrix metalloproteinases in neuroinflammation | Q34803809 |
| | Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes | Q34953482 |
| | Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes | Q34979759 |
| | Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification | Q35038985 |
| | Diabetes, oxidative stress, and antioxidants: a review | Q35077717 |
| | Claudins: control of barrier function and regulation in response to oxidant stress. | Q35130231 |
| | Cerebral microvessel responses to focal ischemia | Q35193869 |
| | Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury. | Q35579664 |
| | Free radical-mediated oxidation of free amino acids and amino acid residues in proteins | Q35602220 |
| | Oxidative stress: the special case of diabetes | Q35646573 |
| | Astrocyte influences on ischemic neuronal death. | Q35699525 |
| | The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) | Q35842779 |
| | Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation | Q36038160 |
| | Emerging roles of thioredoxin cycle enzymes in the central nervous system | Q36068352 |
| | Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways | Q36089228 |
| | Multiple roles for MMPs and TIMPs in cerebral ischemia | Q36104645 |
| | Matrix metalloproteinases and free radicals in cerebral ischemia | Q36144616 |
| | ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability | Q36228711 |
| | Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy | Q36311041 |
| | Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain | Q36348144 |
| | Matrix metalloproteinases (MMPs) in health and disease: an overview | Q36348231 |
| | The multiple languages of endothelial cell-to-cell communication | Q36429966 |
| | Brain cytokines and chemokines: roles in ischemic injury and pain | Q36472230 |
| | Different DNA repair strategies to combat the threat from 8-oxoguanine. | Q36503967 |
| | Novel aspects of oxidative stress-associated carcinogenesis | Q36566519 |
| | Regulation of the phagocyte NADPH oxidase by Rac GTPase | Q36598790 |
| | Redox regulation of human thioredoxin network | Q36598883 |
| | Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells | Q36636052 |
| | Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. | Q36644315 |
| | Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia | Q36871301 |
| | Crosstalk of tight junction components with signaling pathways | Q36976365 |
| | Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes | Q37017921 |
| | Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury | Q37038765 |
| | Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. | Q37066129 |
| | Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle. | Q37078622 |
| | Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy | Q37084522 |
| | Organization of multiprotein complexes at cell-cell junctions | Q37118549 |
| | Assay of 3-nitrotyrosine in tissues and body fluids by liquid chromatography with tandem mass spectrometric detection | Q37142377 |
| | Barriers in the brain: a renaissance? | Q37159965 |
| | Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. | Q42809514 |
| | Prostanoid EP1 receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia | Q43063080 |
| | Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain | Q43139439 |
| | Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element | Q43212996 |
| | Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. | Q43283511 |
| | Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown | Q43616716 |
| | Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy | Q43687875 |
| | FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway | Q44020732 |
| | Nitronyl nitroxides, a novel group of protective agents against oxidative stress in endothelial cells forming the blood-brain barrier | Q44210696 |
| | Oxidative stress in cultured cerebral endothelial cells induces chromosomal aberrations, micronuclei, and apoptosis | Q44401716 |
| | Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway | Q44419517 |
| | Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy | Q44458057 |
| | Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. | Q44711955 |
| | Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia | Q46076015 |
| | SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia | Q46256462 |
| | Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia | Q46414453 |
| | Astrocytes protect neurons from ethanol-induced oxidative stress and apoptotic death | Q46478717 |
| | Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells | Q46552315 |
| | Oxidative stress-induced disruption of epithelial and endothelial tight junctions. | Q46570774 |
| | Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents | Q46761114 |
| | Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries | Q46843126 |
| | TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury | Q46872639 |
| | Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus | Q46946375 |
| | NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke | Q46966136 |
| | Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice | Q47275826 |
| | Differential expression of receptors for advanced glycation end products on monocytes in patients with IDDM. | Q47854228 |
| | Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme | Q47929273 |
| | A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient | Q48161920 |
| | Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. | Q48272602 |
| | Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction | Q48299419 |
| | VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability | Q48387418 |
| | Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. | Q48468454 |
| | Cytotoxic and genotoxic effects of 4-hydroxynonenal in cerebral endothelial cells | Q48562333 |
| | Role of matrix metalloproteinases in delayed cortical responses after stroke | Q48604373 |
| | Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury | Q48698077 |
| | Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. | Q49133201 |
| | Ontogenic expression of the erythroid-type glucose transporter (Glut 1) in the telencephalon of the mouse: correlation to the tightening of the blood-brain barrier | Q50761571 |
| | Perivascular cells of the supraspinatus tendon express both tendon- and stem cell-related markers. | Q51772603 |
| | Nitric oxide redox species exert differential permeability effects on the blood-brain barrier. | Q52538877 |
| | Reactive oxygen species (ROS) in multistage carcinogenesis. | Q53322978 |
| | Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. | Q53430376 |
| | Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology. | Q53569658 |
| | TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. | Q53573824 |
| | Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. | Q55475234 |
| | Role of antioxidant enzymes in brain tumours. | Q55475671 |
| | A gp91phox Containing NADPH Oxidase Selectively Expressed in Endothelial Cells Is a Major Source of Oxygen Radical Generation in the Arterial Wall | Q60723097 |
| | Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation | Q70277032 |
| | Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors | Q71169977 |
| P433 | issue | 5 | |
| P921 | main subject | blood–brain barrier | Q221694 |
| P304 | page(s) | 1305-1323 | |
| P577 | publication date | 2011-05-19 | |
| P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
| P1476 | title | Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases | |
| P478 | volume | 15 | |